Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Conditional disruption of Axin1 leads to development of liver tumors in mice.

Feng GJ, Cotta W, Wei XQ, Poetz O, Evans R, Jardé T, Reed K, Meniel V, Williams GT, Clarke AR, Dale TC.

Gastroenterology. 2012 Dec;143(6):1650-9. doi: 10.1053/j.gastro.2012.08.047. Epub 2012 Sep 6.

PMID:
22960659
2.

Long noncoding RNAs associated with liver regeneration 1 accelerates hepatocyte proliferation during liver regeneration by activating Wnt/β-catenin signaling.

Xu D, Yang F, Yuan JH, Zhang L, Bi HS, Zhou CC, Liu F, Wang F, Sun SH.

Hepatology. 2013 Aug;58(2):739-51. doi: 10.1002/hep.26361. Epub 2013 Jul 1.

PMID:
23483581
3.

Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.

Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, Ross JA, Liu W.

Oncogene. 2002 Jul 18;21(31):4863-71.

4.

Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas.

Zucman-Rossi J, Benhamouche S, Godard C, Boyault S, Grimber G, Balabaud C, Cunha AS, Bioulac-Sage P, Perret C.

Oncogene. 2007 Feb 1;26(5):774-80. Epub 2006 Sep 11.

PMID:
16964294
6.

AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.

Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y, Nakamura Y.

Nat Genet. 2000 Mar;24(3):245-50.

PMID:
10700176
7.

Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas.

Colnot S, Decaens T, Niwa-Kawakita M, Godard C, Hamard G, Kahn A, Giovannini M, Perret C.

Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17216-21. Epub 2004 Nov 24.

8.

Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma.

Kim YD, Park CH, Kim HS, Choi SK, Rew JS, Kim DY, Koh YS, Jeung KW, Lee KH, Lee JS, Juhng SW, Lee JH.

J Gastroenterol Hepatol. 2008 Jan;23(1):110-8. doi: 10.1111/j.1440-1746.2007.05250.x.

PMID:
18171349
9.

5-Hydroxytryptamine promotes hepatocellular carcinoma proliferation by influencing β-catenin.

Fatima S, Shi X, Lin Z, Chen GQ, Pan XH, Wu JC, Ho JW, Lee NP, Gao H, Zhang G, Lu A, Bian ZX.

Mol Oncol. 2016 Feb;10(2):195-212. doi: 10.1016/j.molonc.2015.09.008. Epub 2015 Sep 30.

10.

Coordinated action of Axin1 and Axin2 suppresses β-catenin to regulate muscle stem cell function.

Figeac N, Zammit PS.

Cell Signal. 2015 Aug;27(8):1652-65. doi: 10.1016/j.cellsig.2015.03.025. Epub 2015 Apr 10.

PMID:
25866367
11.

Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.

Ma L, Wang X, Jia T, Wei W, Chua MS, So S.

Oncotarget. 2015 Sep 22;6(28):25390-401. doi: 10.18632/oncotarget.4455.

12.

WNT-3A regulates an Axin1/NRF2 complex that regulates antioxidant metabolism in hepatocytes.

Rada P, Rojo AI, Offergeld A, Feng GJ, Velasco-Martín JP, González-Sancho JM, Valverde ÁM, Dale T, Regadera J, Cuadrado A.

Antioxid Redox Signal. 2015 Mar 1;22(7):555-71. doi: 10.1089/ars.2014.6040. Epub 2014 Dec 9.

13.

Wnt/beta-catenin pathway deregulation in childhood adrenocortical tumors.

Leal LF, Mermejo LM, Ramalho LZ, Martinelli CE Jr, Yunes JA, Seidinger AL, Mastellaro MJ, Cardinalli IA, Brandalise SR, Moreira AC, Tone LG, Scrideli CA, Castro M, Antonini SR.

J Clin Endocrinol Metab. 2011 Oct;96(10):3106-14. doi: 10.1210/jc.2011-0363. Epub 2011 Aug 17.

PMID:
21849527
14.

AXIN1 and AXIN2 variants in gastrointestinal cancers.

Mazzoni SM, Fearon ER.

Cancer Lett. 2014 Dec 1;355(1):1-8. doi: 10.1016/j.canlet.2014.09.018. Epub 2014 Sep 16. Review.

15.

Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas.

Ishizaki Y, Ikeda S, Fujimori M, Shimizu Y, Kurihara T, Itamoto T, Kikuchi A, Okajima M, Asahara T.

Int J Oncol. 2004 May;24(5):1077-83.

PMID:
15067328
16.
17.

Overexpression of Icat induces G(2) arrest and cell death in tumor cell mutants for adenomatous polyposis coli, beta-catenin, or Axin.

Sekiya T, Nakamura T, Kazuki Y, Oshimura M, Kohu K, Tago K, Ohwada S, Akiyama T.

Cancer Res. 2002 Jun 1;62(11):3322-6.

18.

Thr160 of Axin1 is critical for the formation and function of the β-catenin destruction complex.

Koyama-Nasu R, Hayashi T, Nasu-Nishimura Y, Akiyama T, Yamanaka R.

Biochem Biophys Res Commun. 2015 Apr 10;459(3):411-5. doi: 10.1016/j.bbrc.2015.02.118. Epub 2015 Feb 28.

PMID:
25735981
19.

AXIN1 Expression and Localization in Meningiomas and Association to Changes of APC and E-cadherin.

Pećina-Šlaus N, Kafka A, Vladušić T, Pećina HI, Hrašćan R.

Anticancer Res. 2016 Sep;36(9):4583-94.

PMID:
27630299
20.

Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad.

Nejak-Bowen KN, Monga SP.

Semin Cancer Biol. 2011 Feb;21(1):44-58. doi: 10.1016/j.semcancer.2010.12.010. Epub 2010 Dec 21. Review.

Supplemental Content

Support Center